|
Volumn 24, Issue 3, 2001, Pages 290-295
|
Twice-daily prophylactic cranial irradiation for patients with limited disease small-cell lung cancer with complete response to chemotherapy and consolidative radiotherapy: Report of a single institutional phase II trial
a,b a a a a a a |
Author keywords
Central nervous system toxicity; Chemoirradiation; Prophylactic cranial irradiation; SCLC
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADULT;
ARTICLE;
BRAIN METASTASIS;
BRAIN PROTECTION;
CANCER CHEMOTHERAPY;
CANCER PREVENTION;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
LUNG SMALL CELL CANCER;
MALE;
NEUROLOGIC DISEASE;
NEUROTOXICITY;
RADIATION DOSE;
SKULL IRRADIATION;
SURVIVAL RATE;
BRAIN NEOPLASMS;
CARCINOMA, SMALL CELL;
CRANIAL IRRADIATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
SURVIVAL RATE;
|
EID: 0034994380
PISSN: 02773732
EISSN: None
Source Type: Journal
DOI: 10.1097/00000421-200106000-00017 Document Type: Article |
Times cited : (27)
|
References (17)
|